Image

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Testing radiation for slowing cancer spread in advanced lung cancer.

Recruiting
18 years and older
All
Phase 3

This study is for people with a type of lung cancer called non-small cell lung cancer (NSCLC), specifically when it has spread to other parts of the body (metastatic). The study looks at whether adding a special kind of radiation treatment, called radiotherapy, to the usual drugs can better stop the cancer from growing or spreading. Typically, when cancer worsens, doctors change the treatment. But this study tests if radiotherapy can help even more.

For the study, you must be at least 18 years old and have NSCLC that fits certain medical guidelines. You cannot join if you have other specific types of lung cancer or certain medical conditions that make radiation unsafe. Participants will need to be available for treatment and follow-up visits.

  • The study involves adding radiotherapy to regular treatment, which may help stop cancer growth.
  • Participants need to be 18+ and meet specific health criteria.
  • Regular follow-up and treatment visits are required.
Study details
    Non-small Cell Lung Cancer

NCT06686771

Canadian Cancer Trials Group

17 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.